D.A. Davidson & Co’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $695K | Sell |
6,655
-100
| -1% | -$10.4K | ﹤0.01% | 930 |
|
|
2025
Q1 | $788K | Sell |
6,755
-1,475
| -18% | -$172K | 0.01% | 856 |
|
|
2024
Q4 | $696K | Buy |
8,230
+70
| +0.9% | +$5.92K | 0.01% | 902 |
|
|
2024
Q3 | $733K | Sell |
8,160
-1,255
| -13% | -$113K | 0.01% | 880 |
|
|
2024
Q2 | $758K | Buy |
9,415
+375
| +4% | +$30.2K | 0.01% | 831 |
|
|
2024
Q1 | $721K | Buy |
9,040
+1,800
| +25% | +$144K | 0.01% | 845 |
|
|
2023
Q4 | $576K | Sell |
7,240
-190
| -3% | -$15.1K | 0.01% | 902 |
|
|
2023
Q3 | $519K | Sell |
7,430
-15
| -0.2% | -$1.05K | 0.01% | 895 |
|
|
2023
Q2 | $535K | Sell |
7,445
-75
| -1% | -$5.39K | 0.01% | 909 |
|
|
2023
Q1 | $464K | Sell |
7,520
-2,410
| -24% | -$149K | 0.01% | 913 |
|
|
2022
Q4 | $766K | Sell |
9,930
-850
| -8% | -$65.6K | 0.01% | 710 |
|
|
2022
Q3 | $481K | Sell |
10,780
-4,400
| -29% | -$196K | 0.01% | 829 |
|
|
2022
Q2 | $581K | Buy |
15,180
+170
| +1% | +$6.51K | 0.01% | 777 |
|
|
2022
Q1 | $621K | Buy |
15,010
+675
| +5% | +$27.9K | 0.01% | 800 |
|
|
2021
Q4 | $542K | Sell |
14,335
-1,990
| -12% | -$75.2K | 0.01% | 852 |
|
|
2021
Q3 | $538K | Buy |
16,325
+6,990
| +75% | +$230K | 0.01% | 819 |
|
|
2021
Q2 | $630K | Buy |
9,335
+355
| +4% | +$24K | 0.01% | 767 |
|
|
2021
Q1 | $508K | Buy |
8,980
+1,775
| +25% | +$100K | 0.01% | 803 |
|
|
2020
Q4 | $587K | Buy |
7,205
+205
| +3% | +$16.7K | 0.01% | 653 |
|
|
2020
Q3 | $499K | Buy |
7,000
+3,105
| +80% | +$221K | 0.01% | 619 |
|
|
2020
Q2 | $320K | Buy |
+3,895
| New | +$320K | 0.01% | 730 |
|
|
2020
Q1 | – | Sell |
-3,550
| Closed | -$367K | – | 993 |
|
|
2019
Q4 | $367K | Buy |
+3,550
| New | +$367K | 0.01% | 761 |
|